# Scott Kopetz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-kopetz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,567 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 112 |
| i10-index | 486 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5006348751 |
| ORCID iD | https://orcid.org/0000-0001-9647-3416 |
| Works | 1,976 |

## Researcher papers

- [Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study](https://scholariq.org/papers/nivolumab-in-patients-with-metastatic-dna-mismatch-repair-deficient-or/)
- [Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer](https://scholariq.org/papers/durable-clinical-benefit-with-nivolumab-plus-ipilimumab-in-dna-mismatch-repair/)
- [Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer](https://scholariq.org/papers/encorafenib-binimetinib-and-cetuximab-in-i-braf-i-v600e-mutated-colorectal/)
- [Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy](https://scholariq.org/papers/improved-survival-in-metastatic-colorectal-cancer-is-associated-with-adoption-of/)
- [Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer](https://scholariq.org/papers/phase-ii-pilot-study-of-vemurafenib-in-patients-with-metastatic-i-braf-i-mutated/)
- [Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS](https://scholariq.org/papers/pan-asian-adapted-esmo-consensus-guidelines-for-the-management-of-patients-with/)
- [Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018](https://scholariq.org/papers/disparity-of-race-reporting-and-representation-in-clinical-trials-leading-to/)
- [Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance](https://scholariq.org/papers/phase-ii-trial-of-infusional-fluorouracil-irinotecan-and-bevacizumab-for/)
- [ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper](https://scholariq.org/papers/ctdna-applications-and-integration-in-colorectal-cancer-an-nci-colon-and-rectal/)
- [Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes](https://scholariq.org/papers/classifying-colorectal-cancer-by-tumor-location-rather-than-sidedness-highlights/)
- [Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel](https://scholariq.org/papers/validation-of-microsatellite-instability-detection-using-a-comprehensive-plasma/)
- [Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer](https://scholariq.org/papers/deep-sequencing-of-circulating-tumor-dna-detects-molecular-residual-disease-and/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.